Molecular MRI of Intracranial Thrombus in a Rat Ischemic Stroke Model

Background and Purpose— Intracranial thrombus is a principal feature in most ischemic stroke, and thrombus location and size may correlate with outcome and response to thrombolytic therapy. EP-2104R is a fibrin-specific molecular MR agent that has previously been shown to enhance extracranial and venous sinus thrombi in animal models and, recently, in clinical trials. In this study, we examined whether this fibrin-specific MR probe could noninvasively characterize intracranial arterial thrombi. Methods— Embolic stroke was induced in adult rats by occlusion of the right internal carotid artery with an aged thrombus. We used diffusion-weighted imaging, time of flight angiography, and high-resolution 3-dimensional T1-weighted MRI at 4.7 T before and after use of contrast agents EP-2104R (n=6) and gadopentetate dimeglumine (n=5). Results— In all animals, MR angiography revealed a flow deficit and diffusion-weighted imaging showed hyperintensity consistent with ischemia. Using EP-2104R-enhanced MRI, we saw occlusive thrombi and vessel wall enhancement in all 6 animals with high contrast to noise relative to blood, whereas gadopentetate dimeglumine-injected animals showed no occlusive thrombus or vessel wall enhancement. The concentration of gadolinium in the thrombus after EP-2104R was 18 times that in the blood pool. Conclusions— EP-2104R-enhanced MRI successfully identifies intracranial thrombus in a rat embolic stroke model.

[1]  E. Parsons,et al.  Molecular MRI of Cerebral Venous Sinus Thrombosis Using a New Fibrin-Specific MR Contrast Agent , 2007, Stroke.

[2]  B. Kudryk,et al.  Aged venous thrombi: radioimmunoimaging with fibrin-specific monoclonal antibody. , 1987, Radiology.

[3]  J. Mintorovitch,et al.  Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.

[4]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent , 2005, Circulation.

[5]  M. Richardson,et al.  Turnover and fate of fibrinogen and platelets at the rabbit aorta wall immediately after a balloon de-endothelializing injury in vivo , 2006, Thrombosis and Haemostasis.

[6]  C. Francis,et al.  Demonstration of in situ fibrin degradation in pathologic thrombi. , 1984, Blood.

[7]  René M. Botnar,et al.  Molecular MR Imaging of Human Thrombi in a Swine Model of Pulmonary Embolism Using a Fibrin-Specific Contrast Agent , 2007, Investigative radiology.

[8]  A. Divani,et al.  Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? , 2006, Neurology.

[9]  Peter Caravan,et al.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. , 2009, Contrast media & molecular imaging.

[10]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[11]  Peter Caravan,et al.  EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. , 2008, Journal of the American Chemical Society.

[12]  P. Vespa,et al.  Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke , 2006, Stroke.

[13]  René M. Botnar,et al.  Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. , 2005, American journal of respiratory and critical care medicine.

[14]  P. Vespa,et al.  Analysis of Thrombi Retrieved from Cerebral Arteries of Patients with Acute Ischemic Stroke. , 2005 .

[15]  C. Manelfe,et al.  Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. , 1999, Stroke.

[16]  T. Brott,et al.  Hyperdense middle cerebral artery: incidence and quantitative significance , 2004, Neuroradiology.

[17]  Michael Chopp,et al.  A rat model of focal embolic cerebral ischemia , 1997, Brain Research.

[18]  J. Tacke,et al.  Molecular Magnetic Resonance Imaging of Deep Vein Thrombosis Using a Fibrin-Targeted Contrast Agent: A Feasibility Study , 2009, Investigative radiology.

[19]  Zahi A Fayad,et al.  Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent , 2005, Circulation.

[20]  Elmar Spuentrup,et al.  Thrombus Imaging With Fibrin-Specific Gadolinium-Based MR Contrast Agent EP-2104R: Results of a Phase II Clinical Study of Feasibility , 2009, Investigative radiology.

[21]  P. Vespa,et al.  Validation of Computed Tomographic Middle Cerebral Artery “Dot” Sign: An Angiographic Correlation Study , 2003, Stroke.

[22]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[23]  Anne L. Martel,et al.  Characterization of Complicated Carotid Plaque With Magnetic Resonance Direct Thrombus Imaging in Patients With Cerebral Ischemia , 2003, Circulation.

[24]  A. Rudd,et al.  Venous Thromboembolism After Acute Ischemic Stroke: A Prospective Study Using Magnetic Resonance Direct Thrombus Imaging , 2004, Stroke.

[25]  K. Willmes,et al.  The hyperdense posterior cerebral artery sign: a computed tomography marker of acute ischemia in the posterior cerebral artery territory. , 2006, Stroke.

[26]  K. Furie,et al.  Hyperdense Basilar Artery Sign on Unenhanced CT Predicts Thrombus and Outcome in Acute Posterior Circulation Stroke , 2009, Stroke.

[27]  J. Fenoglio,et al.  Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. , 1987, Blood.

[28]  M. Olschewski,et al.  Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.

[29]  D. Leys,et al.  Prevalence and Significance of Hyperdense Middle Cerebral Artery in Acute Stroke , 1992, Stroke.

[30]  N. Petitti.  The hyperdense middle cerebral artery sign. , 1998, Radiology.

[31]  G. Schroth,et al.  Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign , 2008, Stroke.

[32]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model , 2005, Circulation.

[33]  René M. Botnar,et al.  MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients , 2008, European Radiology.

[34]  René M. Botnar,et al.  Molecular Coronary MR Imaging of Human Thrombi using EP-2104R, a Fibrin-Targeted Contrast Agent: Experimental Study in a Swine Model , 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.